Baldwin Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-475
Closed -$9.09K 766
2024
Q3
$9.09K Hold
475
﹤0.01% 810
2024
Q2
$9.83K Hold
475
﹤0.01% 543
2024
Q1
$8.93K Sell
475
-110
-19% -$1.89K ﹤0.01% 563
2023
Q4
$8.44K Sell
585
-509
-47% -$6.92K ﹤0.01% 589
2023
Q3
$19K Sell
1,094
-103
-9% -$2.15K ﹤0.01% 517
2023
Q2
$24.9K Sell
1,197
-181
-13% -$3.93K ﹤0.01% 512
2023
Q1
$32.4K Sell
1,378
-206
-13% -$5.53K ﹤0.01% 478
2022
Q4
$44.2K Buy
1,584
+87
+6% +$2.23K ﹤0.01% 430
2022
Q3
$35K Sell
1,497
-217
-13% -$6.55K ﹤0.01% 375
2022
Q2
$58K Buy
+1,714
New +$60K 0.01% 332
2022
Q1
Sell
-6,237
Closed -$190K 685
2021
Q4
$190K Sell
6,237
-5,876
-49% -$191K 0.02% 204
2021
Q3
$397K Sell
12,113
-6,158
-34% -$197K 0.04% 140
2021
Q2
$553K Buy
+18,271
New +$601K 0.06% 108

Other funds holding OGN

Baldwin Wealth Partners's OGN Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 475 shares — an estimated $9.09K sold.

Baldwin Wealth Partners first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $553K in Q2 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Baldwin Wealth Partners reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 475 Organon & Co shares in Q4 2024, an estimated $9.09K.
  • Baldwin Wealth Partners first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Baldwin Wealth Partners's Organon & Co position peaked at $553K in Q2 2021.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.